WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026
WORK Medical Technology Group announced a 1-for-100 reverse stock split of its Class A and Class B ordinary shares, effective June 18, 2026.
The consolidation will reduce outstanding Class A shares from approximately 241.7 million to about 2.42 million, with trading continuing on Nasdaq under the symbol 'WOK' using a new CUSIP number.
As a supplier of medical devices in China, the company typically files Form 20-F, and this extreme consolidation suggests the stock was trading significantly below exchange minimum bid requirements.